Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk.
Lewington S. and Clarke R., (2005), Circulation, 112, 3373 - 3374
Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk
Lewington S. and Clarke R., (2005), Circulation, 112, 3373 - 3374
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
Fibrinogen Studies Collaboration None. et al, (2005), JAMA, 294, 1799 - 1809
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis
Danesh J. et al, (2005), Journal of the American Medical Association, 294, 1799 - 1809
Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials.
Homocysteine Lowering Trialists' Collaboration None., (2005), Am J Clin Nutr, 82, 806 - 812
Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
Den Heijer M. et al, (2005), J Thromb Haemost, 3, 292 - 299
Tacrine for Alzheimer's disease (Withdrawn Paper. 1999, art. no. CD000202)
Qizilbash N. et al, (2005), COCHRANE DATABASE OF SYSTEMATIC REVIEWS
Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease.
Fibrinogen Studies Collaboration None., (2004), Eur J Cardiovasc Prev Rehabil, 11, 9 - 17
Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis.
Lowe GDO. et al, (2004), Eur Heart J, 25, 252 - 259
The importance of cholesterol, blood pressure and smoking for coronary heart disease.
Lewington S., (2003), Eur Heart J, 24, 1703 - 1704
Homocysteine and prediction of coronary heart disease and stroke
Clarke R. and Lewington S., (2003), Klinicka Biochemie a Metabolismus, 11, 132 - 135
Review: Usual blood pressure is directly related to vascular mortality throughout middle and old age
Lewington S. et al, (2003), Evidence-Based Medicine, 8
Homocysteine, renal function, and risk of cardiovascular disease.
Clarke R. et al, (2003), Kidney Int Suppl, S131 - S133
Age-specific relevance of usual blood pressure to vascular mortality.
Adab P. et al, (2003), Lancet, 361
Age-specific relevance of usual blood pressure to vascular mortality.
Franklin SS. et al, (2003), Lancet, 361
Age-specific relevance of usual blood pressure to vascular mortality.
Fournier A. and Safar M., (2003), Lancet, 361, 1389 - 1390
Age-specific relevance of usual blood pressure to vascular mortality
Adab P. et al, (2003), The Lancet, 361, 1391 - 1391
Regression dilution bias in blood total and high-density lipoprotein cholesterol and blood pressure in the Glostrup and Framingham prospective studies.
Lewington S. et al, (2003), J Cardiovasc Risk, 10, 143 - 148
Homocysteine and risk of cardiovascular disease and venous thrombosis
Clarke R. et al, (2003), THROMBOSIS: FUNDAMENTAL AND CLINICAL ASPECTS, 353 - 370